US 12,290,354 B2
Temperature-compensated analyte monitoring devices, systems, and methods thereof
Gary A. Hayter, Oakland, CA (US); Daniel M. Bernstein, El Granada, CA (US); Martin J. Fennell, Concord, CA (US); Michael R. Love, Pleasanton, CA (US); Kenneth J. Doniger, Menlo Park, CA (US); Songbiao Zhang, Fremont, CA (US); Mark K. Sloan, Hayward, CA (US); Hyun Cho, Berkeley, CA (US); Theodore J. Kunich, Pleasanton, CA (US); Jean-Pierre Cole, Tracy, CA (US); Christopher A. Thomas, San Leandro, CA (US); Erwin S. Budiman, Fremont, CA (US); David L. Li, Fullerton, CA (US); Royce Cheng, San Francisco, CA (US); and Udo Hoss, Castro Valley, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by Abbott Diabetes Care Inc., Alameda, CA (US)
Filed on Jan. 10, 2023, as Appl. No. 18/152,619.
Application 15/873,464 is a division of application No. 13/526,394, filed on Jun. 18, 2012, granted, now 9,974,472, issued on May 22, 2018.
Application 18/152,619 is a continuation of application No. 16/525,915, filed on Jul. 30, 2019, granted, now 11,571,147.
Application 16/525,915 is a continuation of application No. 15/873,464, filed on Jan. 17, 2018, granted, now 10,398,363, issued on Sep. 3, 2019.
Claims priority of provisional application 61/497,821, filed on Jun. 16, 2011.
Prior Publication US 2023/0143496 A1, May 11, 2023
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/01 (2006.01); A61B 5/1473 (2006.01)
CPC A61B 5/14532 (2013.01) [A61B 5/01 (2013.01); A61B 5/14503 (2013.01); A61B 5/7225 (2013.01); A61B 5/1473 (2013.01); A61B 2560/0252 (2013.01); A61B 2562/0271 (2013.01)] 12 Claims
OG exemplary drawing
 
7. A glucose monitoring system, comprising:
a glucose monitoring device, comprising:
a first processor and a first memory communicably coupled to the first processor;
an in vivo glucose sensor comprising a sensing area communicably coupled to the first processor, wherein the in vivo glucose sensor comprises a first portion configured to be arranged above a skin surface of a user and a second portion configured to be positioned below the skin surface and in contact with interstitial fluid, wherein the second portion comprises the sensing area; and
a temperature sensor communicably coupled to the first processor, wherein the temperature sensor is disposed in a housing and is configured to be arranged above the skin surface of the user; and
a receiver configured to communicate with the glucose monitoring device, the receiver comprising:
a second processor and a second memory communicably coupled to the second processor;
wherein at least one of the first memory and the second memory includes instructions stored therein that, when executed by at least one of the first and second processors, cause the at least one of the first and second processors to:
receive a sensor signal from the in vivo glucose sensor;
detect a temperature measurement from the temperature sensor;
determine an ambient-compensated temperature from the temperature measurement using an offset term based on a core body temperature, wherein the ambient-compensated temperature is an estimated temperature of the sensing area; and
determine a temperature-compensated glucose sensor signal with the thus determined ambient-compensated temperature.